Circulating platelets in experimental models of atherosclerosis, as well in condtions linked to atherogenesis in humans, are activated, as shown by our ultrastructural studies, demonstrating for the first time their morphological/morphometrical features. Prostacyclin and 8-chlorocarbochromen (but not acetylsalicylic acid) are able to inhibit in vitro and in vivo (8-chlorocarbochromen) the process.
Bianciardi, G., Toti, P., Weber, G. (1986). Ultrastructural aspects of platelets in atherosclerosis and related diseases. ANGEIOLOGIE, 38(1), 11-21.
Ultrastructural aspects of platelets in atherosclerosis and related diseases
BIANCIARDI, G.;TOTI, P.;
1986-01-01
Abstract
Circulating platelets in experimental models of atherosclerosis, as well in condtions linked to atherogenesis in humans, are activated, as shown by our ultrastructural studies, demonstrating for the first time their morphological/morphometrical features. Prostacyclin and 8-chlorocarbochromen (but not acetylsalicylic acid) are able to inhibit in vitro and in vivo (8-chlorocarbochromen) the process.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/20104
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo